Cerenia Injectable
سيرينيا محلول للحقن
Cerenia (maropitant citrate) Injectable Solution is a neurokinin-1 (NK1) receptor antagonist indicated for the prevention and treatment of acute vomiting in dogs and cats, as well as prevention of vomiting associated with emetogenic medications.
Dosage Form
Injection
Product Type
Pharmaceutical
Manufacturer
Package
20 mL amber glass multi-dose vial containing 10 mg/mL maropitant
Dosages
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Dog | 1.0 mg/kg (0.1 mL/10 kg) | Subcutaneous (SC) or Intravenous (IV) | Once daily for up to 5 consecutive days |
| Cat | 1.0 mg/kg (0.1 mL/10 kg) | Subcutaneous (SC) or Intravenous (IV) | Once daily for up to 5 consecutive days |
Withdrawal Periods
No withdrawal information available.
Indications
-
Prevention and treatment of acute vomiting in dogs and cats.
-
Prevention of vomiting associated with pre-anesthetic use of emetogenic medications (such as morphine or hydromorphone) in dogs.
Contraindications
-
Do not use in animals with known hypersensitivity to maropitant.
-
Do not use in puppies under 8 weeks of age or kittens under 16 weeks of age.
Precautions
-
Use with caution in animals with suspected or known gastrointestinal foreign body or obstruction.
-
Use with caution in patients with hepatic dysfunction, as maropitant is primarily metabolized by the liver.
-
Safety has not been evaluated in breeding, pregnant, or lactating dogs or cats.
Side Effects
-
Pain or stinging sensation at the subcutaneous injection site.
-
Lethargy, anorexia, diarrhea, or ataxia in rare cases.
Images
Documents
-
Download
Cerenia Injectable Prescribing Information
Leaflet
Active Ingredients
-
Maropitant citrate
10 mg/mL
Diseases
No diseases linked.
Related Products
No data available
Information has not been added yet.
Related Products By Active Ingredient
Companies
-
Zoetis
Manufacturer
Alternatives
No alternatives available.